Abstract
Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia.
Highlights
Gestational trophoblastic neoplasia (GTN) is a rare tumor that arises from placental tissues and exhibits a high cure rate when treated with cytotoxic chemotherapy.[1]
While GTN is highly sensitive to chemotherapy, it is important to differentiate which patients will respond to single-agent chemotherapy versus those that will require more morbid, multiagent regimens to achieve remission.[3,4]
Since GTN treatment is directly related to the Federation of Gynecology and Obstetrics (FIGO) prognostic score,[5] correct assessment of score is essential for the appropriate selection of chemotherapy
Summary
Gestational trophoblastic neoplasia (GTN) is a rare tumor that arises from placental tissues and exhibits a high cure rate when treated with cytotoxic chemotherapy.[1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
